In the next few decades, the world population will flourish. As the population grows rapidly and people all over the world use more and more resources, all industries must consider their environmental impact. 2302-25-2, name is 4-Bromo-1H-imidazole belongs to imidazoles-derivatives compound, it is a common compound, a new synthetic route is introduced below. Recommanded Product: 4-Bromo-1H-imidazole
[00328] To a flask was added 4-bromo-5H-imidazole (approximately 455 mg, 3.1 mmol) in N-methylpyrrolidine (6 mL) and 3,5-difluoropyridine (366 mg, 3.1 mmol) and potassium carbonate (429 mg, 3.1 mmol). The reaction was heated at 100 C for 12 hours. LCMS showed the formation of the product. The reaction was filtered and the crude product was purified by reverse phase chromatography (CI 8 100 g column (ISCO);10-90% water/acetonitrile with a trifluoroacetic acid modifier) to afford purified product. The fraction were combined and neutralized with an SPE-CO3H cartridge to afford the desired product.
The synthetic route of 2302-25-2 has been constantly updated, and we look forward to future research findings.
Reference:
Patent; VERTEX PHARMACEUTICALS INCORPORATED; COLLIER, Philip, N.; DAVIES, Robert, J.; DENINNO, Michael, Paul; DOYLE, Elisabeth; FRANTZ, James, Daniel; GOLDMAN, Brian, Anthony; GRILLOT, Anne-Laure; KOLPAK, Adrienne, Lynne; KRAUSS, Raul, Eduardo; LEDFORD, Brian; LIAO, Yusheng; MAGAVI, Sanjay, Shivayogi; MALTAIS, Francois; PEROLA, Emanuele; RYU, Elizabeth, Jin-Sun; SYKEN, Joshua; TANG, Qing; WANG, Tiansheng; (221 pag.)WO2018/106643; (2018); A1;,
Imidazole – Wikipedia,
Imidazole | C3H4N2 – PubChem